About Hawthorne Health
Hawthorne Health is a private company based in Roseville, California. It has reported $2,494,762 raised in two offerings on Form D since August 2026. Its chief executive is Joshua Rose.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Aug 13, 2026 | $2,484,055of $5.5M target | 6 | $414K | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 26, 2025 | Aug 13, 2026 | $10,707target not set | 1 | $10,707 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $2,494,762 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hawthorne Health's Form D filed Aug 13, 2026.
AC
Antonio Clapsis
Director
JR
JD
Jonathan DiVincenzo
President and Chief Operating Officer, Bio-Rad Laboratories, director
MM
Andrea Jackson
Partner, Northpond Ventures and director
Richard Daly
Chairman, VieCure; Former CEO, DNAnexus
Sources
- SECHawthorne Health, Inc. filing history
- CompanyContact
- CompanyOur Story
- CompanyLeadership
- CompanySCRS collaboration announcement